Cargando…
Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23–68% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to pr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107279/ https://www.ncbi.nlm.nih.gov/pubmed/33981257 http://dx.doi.org/10.3389/fpsyt.2021.641430 |
_version_ | 1783689925608079360 |
---|---|
author | Delorme, Jessica Pennel, Lucie Brousse, Georges Daulouède, Jean-Pierre Delile, Jean-Michel Lack, Philippe Gérard, Antoine Dematteis, Maurice Kabore, Jean-Luc Authier, Nicolas Chenaf, Chouki |
author_facet | Delorme, Jessica Pennel, Lucie Brousse, Georges Daulouède, Jean-Pierre Delile, Jean-Michel Lack, Philippe Gérard, Antoine Dematteis, Maurice Kabore, Jean-Luc Authier, Nicolas Chenaf, Chouki |
author_sort | Delorme, Jessica |
collection | PubMed |
description | Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23–68% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to provide European estimates of the prevalence of chronic pain in patients receiving OAT using French data, since France is the first European country in terms of number of patients with OAT. The secondary objectives were to characterize the features and management of chronic pain, as well identify associated risk factors. We conducted a multicenter, cross-sectional study, recruiting patients treated either with buprenorphine or methadone in 19 French addiction centers, from May to July 2016. All participants had to complete a semi-directed questionnaire that collected sociodemographic and medical data, pain characteristics, and licit or illicit drug consumption. In total, 509 patients were included. The prevalence of chronic pain was estimated at 33.2% (95% CI: 29.1–37.3). Compared to non-chronic pain patients, chronic pain patients were older (38.4 vs. 36.1 years, p = 0.006), were more unemployed (66 vs. 52%, p = 0.003), had more psychiatric comorbidities (50 vs. 39%, p = 0.02), and split their OAT for pain management more frequently (24 vs. 7%, p = 0.009). Pain intensity was moderate or severe in 75% of chronic pain patients. Among patients with chronic pain, 15.4% were not prescribed, and did not self-medicate with, any analgesic drugs, 52.1% were prescribed analgesics (non-opioid analgesics, 76.3%; codeine, tramadol, opium, 27.2%; and morphine, fentanyl, oxycodone, 11.8%), and 32.5% exclusively self-medicated with analgesics. Moreover, 20.1% of patients with chronic pain also used illicit drugs for pain relief. On multivariate analysis, variables that remained significantly associated with chronic pain were age [OR = 1.03 (95% CI: 1.00–1.05], p = 0.02], anxiety [OR = 1.52 (1.15–2.02), p = 0.003], and depression [OR = 1.25 (1.00–1.55), p = 0.05]. Chronic pain is a highly prevalent condition in patients receiving OAT, and its appropriate management remains uncertain, since insufficient relief and frequent additional self-medications with analgesics or illicit drugs were reported by these patients. Increased awareness among caregivers is urgently needed regarding a systematic and careful assessment, along with an adequate management of chronic pain in patients receiving OAT. |
format | Online Article Text |
id | pubmed-8107279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81072792021-05-11 Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients Delorme, Jessica Pennel, Lucie Brousse, Georges Daulouède, Jean-Pierre Delile, Jean-Michel Lack, Philippe Gérard, Antoine Dematteis, Maurice Kabore, Jean-Luc Authier, Nicolas Chenaf, Chouki Front Psychiatry Psychiatry Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23–68% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to provide European estimates of the prevalence of chronic pain in patients receiving OAT using French data, since France is the first European country in terms of number of patients with OAT. The secondary objectives were to characterize the features and management of chronic pain, as well identify associated risk factors. We conducted a multicenter, cross-sectional study, recruiting patients treated either with buprenorphine or methadone in 19 French addiction centers, from May to July 2016. All participants had to complete a semi-directed questionnaire that collected sociodemographic and medical data, pain characteristics, and licit or illicit drug consumption. In total, 509 patients were included. The prevalence of chronic pain was estimated at 33.2% (95% CI: 29.1–37.3). Compared to non-chronic pain patients, chronic pain patients were older (38.4 vs. 36.1 years, p = 0.006), were more unemployed (66 vs. 52%, p = 0.003), had more psychiatric comorbidities (50 vs. 39%, p = 0.02), and split their OAT for pain management more frequently (24 vs. 7%, p = 0.009). Pain intensity was moderate or severe in 75% of chronic pain patients. Among patients with chronic pain, 15.4% were not prescribed, and did not self-medicate with, any analgesic drugs, 52.1% were prescribed analgesics (non-opioid analgesics, 76.3%; codeine, tramadol, opium, 27.2%; and morphine, fentanyl, oxycodone, 11.8%), and 32.5% exclusively self-medicated with analgesics. Moreover, 20.1% of patients with chronic pain also used illicit drugs for pain relief. On multivariate analysis, variables that remained significantly associated with chronic pain were age [OR = 1.03 (95% CI: 1.00–1.05], p = 0.02], anxiety [OR = 1.52 (1.15–2.02), p = 0.003], and depression [OR = 1.25 (1.00–1.55), p = 0.05]. Chronic pain is a highly prevalent condition in patients receiving OAT, and its appropriate management remains uncertain, since insufficient relief and frequent additional self-medications with analgesics or illicit drugs were reported by these patients. Increased awareness among caregivers is urgently needed regarding a systematic and careful assessment, along with an adequate management of chronic pain in patients receiving OAT. Frontiers Media S.A. 2021-04-26 /pmc/articles/PMC8107279/ /pubmed/33981257 http://dx.doi.org/10.3389/fpsyt.2021.641430 Text en Copyright © 2021 Delorme, Pennel, Brousse, Daulouède, Delile, Lack, Gérard, Dematteis, Kabore, Authier, Chenaf and TOXIDOL Study group. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Delorme, Jessica Pennel, Lucie Brousse, Georges Daulouède, Jean-Pierre Delile, Jean-Michel Lack, Philippe Gérard, Antoine Dematteis, Maurice Kabore, Jean-Luc Authier, Nicolas Chenaf, Chouki Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients |
title | Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients |
title_full | Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients |
title_fullStr | Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients |
title_full_unstemmed | Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients |
title_short | Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients |
title_sort | prevalence and characteristics of chronic pain in buprenorphine and methadone-maintained patients |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107279/ https://www.ncbi.nlm.nih.gov/pubmed/33981257 http://dx.doi.org/10.3389/fpsyt.2021.641430 |
work_keys_str_mv | AT delormejessica prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT pennellucie prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT broussegeorges prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT daulouedejeanpierre prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT delilejeanmichel prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT lackphilippe prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT gerardantoine prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT dematteismaurice prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT kaborejeanluc prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT authiernicolas prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT chenafchouki prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients AT prevalenceandcharacteristicsofchronicpaininbuprenorphineandmethadonemaintainedpatients |